These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 855811

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives.
    Sheu WH, Hsu CH, Chen YS, Jeng CY, Fuh MM.
    Clin Endocrinol (Oxf); 1994 Feb; 40(2):249-55. PubMed ID: 8137525
    [Abstract] [Full Text] [Related]

  • 5. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.
    Straznicky NE, Barrington VE, Branley P, Louis WJ.
    J Hypertens; 1998 Mar; 16(3):357-68. PubMed ID: 9557929
    [Abstract] [Full Text] [Related]

  • 6. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN.
    Am J Obstet Gynecol; 1982 Mar 15; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [Abstract] [Full Text] [Related]

  • 7. Effect of oral contraceptives and vitamin B6 supplements on alanine and glycine metabolism.
    Rose DP, Leklem JE, Brown RR, Potera C.
    Am J Clin Nutr; 1976 Sep 15; 29(9):956-60. PubMed ID: 961624
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Sep 15; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes in insulin receptors during oral contraception.
    De Pirro R, Forte F, Bertoli A, Greco AV, Lauro R.
    J Clin Endocrinol Metab; 1981 Jan 15; 52(1):29-33. PubMed ID: 7451643
    [Abstract] [Full Text] [Related]

  • 16. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W, Foidart JM, Dombrovicz N, Welter A, Heithecker R.
    J Clin Endocrinol Metab; 1995 Jun 15; 80(6):1816-21. PubMed ID: 7775629
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term effects of the combined oral contraceptive pill on carbohydrate and lipid metabolism in Singapore women--a cross-sectional study.
    Ng CS, Chng JW, Oakley NW, Wynn V, Ratnam SS.
    Ann Acad Med Singap; 1982 Oct 15; 11(4):567-74. PubMed ID: 6762138
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.